AstraZeneca Pharma India Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ASTRAZEN.BO | IPCALAB.BO | IOLCP.NS | SUNPHARMA.BO | ABBOTINDIA.NS | APLLTD.NS | |
|---|---|---|---|---|---|---|
| Market cap | — | 490.54B | 55.50B | 4.38T | 565.34B | 175.63B |
| P/E (TTM) | 95.1 | 37.9 | 27.3 | 40.1 | 35.0 | 20.8 |
| Forward P/E | — | 27.5 | 17.5 | 32.3 | 29.4 | 18.2 |
| Price/book | 18.4 | 6.1 | 2.9 | 5.6 | 11.8 | 3.0 |
| Dividend yield | 0.57% | 0.30% | 0.54% | 0.97% | 1.94% | 1.32% |
| 1-year change | −30.91% | +49.60% | +87.93% | −2.21% | −7.93% | −0.94% |
| Today | +1.01% | −2.01% | +2.89% | +2.78% | −1.90% | −1.46% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All ASTRAZEN.BO news ›AstraZeneca Pharma India ESG Rating 73 FY2025-26
Kalkine India AstraZeneca Pharma India (NSE:ASTRAZEN): What Does Its ESG Rating of 73 Mean? Source: Krish Capital Pty Ltd AstraZeneca Pharma India Limited (NSE:ASTRAZEN) disclosed on 16 October 2026 that NSE Sustainability Ratings and…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.co.in1
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.